Country

Clinical trials in Iran

Active obesity and GLP-1 studies with at least one location in Iran.

6active studies
2recruiting now
1countries represented
1largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

PCO - Polycystic Ovaries, Obesity and Obesity-related Medical ConditionsCondition
Subjects in the intervention group will receive one capsule containing 10 mg Astaper day made by the "Zyest Technology Tarawat Zendig" institute in Iran. The dosage of ASX is determined based on the s, PlaceboTreatment
Iran1 locations
Isfahan University of Medical SciencesSponsor
Updated 2024-10-17 · NCT06642363See eligibility →

Related countries

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.